Showing results (341-350 of 436) with videos related to

Sort By:
Pageof 44
Circulation|June 10, 2010
Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic targetStephen L Archer, Glenn Marsboom, Gene H Kim, et al.
Molecules (Basel, Switzerland)|August 28, 2020
Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor DrugsMohamed Salla, Vrajesh Pandya, Khushwant S Bhullar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2015
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotypeEmily K Mathey, Susanna B Park, Richard A C Hughes, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 3, 2020
Layer-specific strain in patients with heart failure using cardiovascular magnetic resonance: not all layers are the sameLingyu Xu, Joseph J Pagano, Mark J Haykowksy, et al.
The Journal of Biological Chemistry|June 8, 2004
Regulation of malonyl-CoA concentration and turnover in the normal heartAneta E Reszko, Takhar Kasumov, France David, et al.
Plos One|February 26, 2013
Calreticulin induces dilated cardiomyopathyDukgyu Lee, Tatsujiro Oka, Beth Hunter, et al.
Journal of Molecular and Cellular Cardiology|November 2, 2018
Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolitesNobutoshi Matsumura, Shingo Takahara, Zaid H Maayah, et al.
Muscle & Nerve|March 16, 2018
Somatotopic heat pain thresholds and intraepidermal nerve fibers in healthJenny L Davies, Janean K Engelstad, Linde E Gove, et al.
Circulation|April 16, 2003
In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic ratsZlatko I Pozeg, Evangelos D Michelakis, M Sean McMurtry, et al.
Circulation|July 4, 2007
Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractilityJayan Nagendran, Stephen L Archer, Daniel Soliman, et al.
Pageof 44